Literature DB >> 36194805

Implementation and Uptake of the Massachusetts Drug Supply Data Stream: A Statewide Public Health-Public Safety Partnership Drug Checking Program.

Traci C Green1, Rebecca Olson, Cole Jarczyk, Earth Erowid, Fire Erowid, Sylvia Thyssen, Rachel Wightman, Brandon Del Pozo, Laura Michelson, Amanda Consigli, Brittni Reilly, Sarah Ruiz.   

Abstract

CONTEXT: The illicit drug supply is rapidly evolving. Equally important to gathering drug supply data for monitoring is timely sharing of information with people who use drugs, the providers who care for them, law enforcement partners, and public health stakeholders so that efforts to avoid harmful substances, take preventive actions, and better target interventions can occur. PROGRAM: The Massachusetts Drug Supply Data Stream (MADDS) is the country's first statewide community drug checking program. Founded on public health-public safety partnerships, MADDS collects remnant drug packaging and paraphernalia with residue from people who use drugs and noncriminal samples from partnering police departments. MADDS tests samples using simultaneous immunoassay fentanyl test strips, Fourier-transform infrared spectrometry (FTIR), and off-site laboratory testing by gas chromatography-mass spectrometry (GC/MS). Results are accessible to community programs and municipalities, while trend analyses inform public health for cross-site alerts and informational bulletins. IMPLEMENTATION: MADDS was launched statewide in 2020 and rapidly expanded to a multisite program. Program staff approached communities and met with municipal police and community partners to secure written agreements to host drug checking. Community partners designed sample collection consistent with their pandemic era workflows. Consultations with stakeholders gathered feedback on design and deliverables. EVALUATION: The program tests sample donations on-site from community agencies and police departments, incorporates review by a medical toxicologist for health and safety concerns, crafts stakeholder-specific communications, and disseminates English, Spanish, and Portuguese language materials. For 2020, a total of 427 samples were tested, of which 47.1% were positive for fentanyl. By early 2021, MADDS detected shifts in cocaine purity, alerted communities of a new toxic fentanyl analogue and a synthetic cannabinoid contaminant, and confirmed the increase of xylazine (a veterinary sedative) in Massachusetts. DISCUSSION: Community drug checking programs can be collaboratively designed with public health and public safety to generate critical health and safety information for people who use drugs and the communities where they live.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36194805      PMCID: PMC9531987          DOI: 10.1097/PHH.0000000000001581

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  33 in total

1.  Perceived occupational risk of fentanyl exposure among law enforcement.

Authors:  Peyton R Attaway; Hope M Smiley-McDonald; Peter J Davidson; Alex H Kral
Journal:  Int J Drug Policy       Date:  2021-06-02

2.  Cocaine use and crack babies: science, the media, and miscommunication.

Authors:  N L Day; G A Richardson
Journal:  Neurotoxicol Teratol       Date:  1993 Sep-Oct       Impact factor: 3.763

3.  Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.

Authors:  Susan G Sherman; Kenneth B Morales; Ju Nyeong Park; Michelle McKenzie; Brandon D L Marshall; Traci Craig Green
Journal:  Int J Drug Policy       Date:  2019-04-13

4.  Differences and similarities between emergency department syndromic surveillance and hospital discharge data for nonfatal drug overdose.

Authors:  Alana M Vivolo-Kantor; Herschel Smith; Lawrence Scholl
Journal:  Ann Epidemiol       Date:  2021-06-06       Impact factor: 3.797

5.  Results from a mobile drug checking pilot program using three technologies in Chicago, IL, USA.

Authors:  Lydia Karch; Samuel Tobias; Clare Schmidt; Maya Doe-Simkins; Nicole Carter; Elizabeth Salisbury-Afshar; Suzanne Carlberg-Racich
Journal:  Drug Alcohol Depend       Date:  2021-08-28       Impact factor: 4.492

6.  Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.

Authors:  Tibor M Brunt; Constanze Nagy; Alexander Bücheli; Daniel Martins; Miren Ugarte; Cécile Beduwe; Mireia Ventura Vilamala
Journal:  Drug Test Anal       Date:  2016-02-17       Impact factor: 3.345

7.  High willingness to use rapid fentanyl test strips among young adults who use drugs.

Authors:  Maxwell S Krieger; Jesse L Yedinak; Jane A Buxton; Mark Lysyshyn; Edward Bernstein; Josiah D Rich; Traci C Green; Scott E Hadland; Brandon D L Marshall
Journal:  Harm Reduct J       Date:  2018-02-08

8.  Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019.

Authors:  Christine L Mattson; Lauren J Tanz; Kelly Quinn; Mbabazi Kariisa; Priyam Patel; Nicole L Davis
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-02-12       Impact factor: 17.586

Review 9.  Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications.

Authors:  Arianna Giorgetti; Jennifer P Pascali; Paolo Fais; Guido Pelletti; Andrea Gabbin; Giorgia Franchetti; Giovanni Cecchetto; Guido Viel
Journal:  Life (Basel)       Date:  2021-05-14

10.  Preventative health, diversity, and inclusion: a qualitative study of client experience aboard a mobile health clinic in Boston, Massachusetts.

Authors:  Zoe Bouchelle; Yasmin Rawlins; Caterina Hill; Jennifer Bennet; Leonor Xochitl Perez; Nancy Oriol
Journal:  Int J Equity Health       Date:  2017-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.